Needle-free Injectors Market Size, Share & Trends Analysis Report By Product (Fillable, Prefilled), By Technology, By Type (Liquid-based Needle-free Injectors), By Usability, By Application (Vaccine Delivery), By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global needle free-injectors market size was estimated at USD 1.3 billion in 2022 and expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2030. Increasing number of regulatory approvals, rising preference for self-administration of drugs are expected to foster market growth. Needle-free devices provide pain less delivery and negate the risk of infection. Hence, the demand for these injectors is projected to rise during the forecast period. 

The COVID-19 pandemic has positive impact on needle-free injectors market. The requirement and demand for mass vaccination needs and self-injectable devices have increased since the initiation of COVID-19. As COVID-19 cases have increased in all regions, the majority of the needle free-injectors market players have participated in R&D activities and started entering into agreements and partnerships with other industry firms and government organizations to develop and improve needle free-injectors. 

Needle-free injectors provide higher safety for patients and healthcare workers by eliminating risks related to conventional infusion and injection technology such as drug preparation, needle insertion, and covering & disposing of needles. In addition, American Nurses Association stated that around 74.0% of accidental needlestick injuries are due to contamination and are likely to lead to infection. Treatments for these injuries is expensive. According to the CDC, treatment cost ranges from USD 500 to USD 3,000 or more per injury. These costs get multiplied during infection. The CDC has also projected that the number of needle stick injuries reported each year in hospitals in the U.S. is 385,000. On the other hand, European Agency of Safety and Health at Work stated that about 1.0 million needlestick injuries occur every year across the world. 

Rising healthcare costs is the biggest concern faced by developing and developed economies. These regions are struggling to address cost-effective and quality care. Despite supportive health funding and insurance program, there has been a constant rise in healthcare cost in the U.S., which is influencing healthcare providers. Healthcare expenditure in the U.S. is around 2.4 times higher than the global average and is anticipated to increase by 68.0% in the coming ten years. With the help of needle-free injectors, patients can self-administer the drug subcutaneously at home, this is anticipated to reduce the number of visits to hospitals or other healthcare settings, thereby helping patients to limit their healthcare expenses. 

Product Insights 

The fillable segment held the largest revenue share in 2022 owing to their high adoption rates and wide availability throughout the globe. The prefilled segment held a considerable market share in 2022. Increasing application of prefilled needle-free injectors in insulin, vaccination, and other drug delivery is projected to augment the market growth. Surging preference for prefilled needle-free injectors by several healthcare professionals may strengthen the market growth.

Usability Insights 

The reusable segment dominated the needle-free injectors market and accounted for a significant revenue share in 2021.  Reusable needle free-injectors are mostly suggested by healthcare specialists as well as doctors to reduce the risk of infections and other harmful ailments. Reusable injectors provide excessive durability as they are manufactured from superior and precision-engineered materials, which also help doctors to reuse them several times. 

The disposable segment accounted for the largest revenue share in 2022. Disposable needle free-injectors are easy to use for numerous, low-volume injections or variable dosing. Increasing awareness regarding benefits provided by drug delivery devices and surging concerns over the hazards related to needle stick injuries may enhance the segment growth. 

Technology Insights 

The gas powered needle-free injectors segment held the largest revenue share in 2022.  Gas powered needle-free injectors are suitable for transdermal, subcutaneous, or intramuscular use. Increasing benefits associated with this technology, including improved dosage accuracy, rapid drug administration, faster response rate, and better diffusion into the tissue are predicted to augment the market demand. 

Laser-powered needle-free injectors segment held a considerable market share in 2021. Recent advancements and innovations in laser powered needle-free injectors are anticipated to propel market growth.

Type Insights 

The segmental growth is attributed to the increasing ability of a liquid jet to penetrate the skin and underlying fat layer without harming the integrity of the drug molecule or harming the skin. Hence surging demand for liquid-based needle-free injectors is anticipated to foster market growth. The powder-based needle free injectors segment held a significant CAGR during the forecast period. Several market players across the globe are focusing on developing powder-based needle-free injectors to strengthen their product portfolio. 

Delivery Site Insights 

The subcutaneous segment held the largest market share in 2022. The segmental growth is attributed to the greater effect as the drug moves to the capillaries and is carried to the bloodstream. The intradermal segment accounted for a significant CAGR during the progression period. Increasing preference for intradermal administration by several patients across the globe is anticipated to fuel market growth. 

Application Insights 

Vaccine delivery is among the leading application segment in needle-free injectors market. Increasing preference for vaccine administration is predicted to surge the demand for needle free-injectors during the forecast period. The pain management segment is expected to witness a significant CAGR during the forecast period. Increasing cases of medical conditions such as pain disorders, arthritis, and migraine is predicted to secure the market position.

End-use Insights 

The hospitals segment captured the largest revenue share of in 2022. Hospitals require needle-free injectors in large quantities at nurse’s stations, operation theaters, emergency rooms, outpatient departments, and ambulatory services. Hospitals generally issue an open tender for the procurement of such devices. Growing hospitalization of patients coupled with a surge in the number of hospitals across the world is expected to contribute to market growth during the forecast period. 

The homecare settings segment gained momentous growth in 2022. Advanced features of needle-free injectors are improving patient adherence toward drug delivery devices, and this is expected to aid in the growth of the home care segment. 

Regional Insights 

North America is anticipated to dominate the market at 42.5% in 2022 and is expected to grow over the forecast period owing to the presence of major market players in the U.S. coupled with the increasing prevalence of chronic and lifestyle-associated diseases. In addition, the growing trend was found throughout the U.S. and among Canadian citizens towards self-administration of medications. Hence the above-mentioned factors are anticipated to boost regional growth.

Europe accounted for the second-highest revenue share and is expected to witness a substantial CAGR during the forecast period. Advancements in medical technologies, rising adoption of needle-free injectors, and increasing healthcare spending are expected to contribute to the market growth during the forecast period. 

Asia Pacific is expected to register the fastest CAGR around 8.16% over the forecast period, which can be attributed to favorable government initiatives for use of medical devices, increasing geriatric population base, and increasing healthcare expenditure in this region. Increase in aging population in several Asian countries, which is highly prone to chronic diseases, is expected to fuel the demand for needle-free injectors. 

Key Companies & Market Share Insights 

Major companies functioning in needle free-injectors market have well-known vigorous business strategies such as strategic partnerships and collaborations, joint ventures, mergers & acquisitions, new product launches & product innovation, to expand their market reach. Some of the prominent players in the needle free-injectors market include:

• PharmaJet

• Crossject

• Portal Instruments

• NuGen Medical Devices

• Inovio Pharmaceuticals

• Antares Pharma, Inc

• Aijex Pharma International Inc.

• Ferring B.V.

• Penjet Corporation

• Medical International Technology Inc.  

Needle-free Injectors Market Report Scope 

Global Needle-free Injectors Market Segmentation 

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global needle-free injectors market report based on product, technology, usability, type, application, delivery site, end-use, and region: 

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Fillable

  • Prefilled

• Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • Spring-based Needle-free Injectors

  • Gas-powered Needle-free Injectors

  • Laser-powered Needle-free Injectors

  • Vibration-based Needle-free Injectors

• Usability Outlook (Revenue, USD Million, 2018 - 2030)

  • Disposable

  • Reusable

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Powder-based Needle Free Injectors

  • Liquid-based Needle Free Injectors

  • Projectile/depot-based Needle Free Injectors

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Vaccine Delivery

  • Insulin Delivery

  • Pain Management

  • Others

• Delivery Site Outlook (Revenue, USD Million, 2018 - 2030)

  • Subcutaneous

  • Intramuscular

  • Intradermal

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Clinics

  • Home Care Settings

  • Research Laboratories

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE